THE LONG-ACTING GLP-2 ANALOG APRAGLUTIDE PROVIDES CLINICAL BENEFIT FOR PATIENTS WITH SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE AND COLON IN CONTINUITY AT 52 WEEKS

Astrid Verbiest  1, 2     Mark Krogh Hvistendahl  3     Federico Bolognani  4     Carrie Li  4     Nader Youssef  4     Palle Bekker Jeppesen  4     Francisca Joly  5     Tim Vanuytsel  2, 1    
1 University of Leuven, Leuven, Belgium
2 University Hospitals Leuven, Leuven, Belgium
3 Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
4 VectivBio AG, Basel, Switzerland
5 Hôpital Beaujon, Clichy, France

Topic
IBD, Small Intestine & Nutrition

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing